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ABSTRACT
OBJECTIVE: To analyze whether the actions of early detection of breast cancer, initiated with 
the medical request for mammography, differ between users of the Brazilian Unified Health 
System (SUS) and those who have private health insurance.
METHODS: From the data collected in the National Health Survey, we estimated the proportions 
of women who had medical request for mammography according to presence or absence of 
private health insurance. For assessing the factors related to having mammography medical 
request, we estimated crude and adjusted odds ratios and respective 95%CI by logistic regression. 
We also analyzed the main reasons reported for not having performed mammography after 
medical request, as well as the time between examination and result.
RESULTS: Of the women interviewed, 66.7% had a medical request for mammography (59.4% 
among SUS users and 83.9% among those with private health insurance). Having private health 
insurance, higher education level, and being white were positively associated with having the 
medical request. Only 5.4% (95%CI 4.8–6.0) of women who received medical request failed to 
perform mammography – 7.6% were SUS users and 1.7% had health insurance. The most reported 
reasons for not being able to perform the examination were: not thinking it was necessary; 
having the test scheduled, but not yet performed; and not being able to schedule it. More than 
70% of women received the result with less than one month from its execution. 
CONCLUSIONS: The barriers to access a medical request for mammographic screening for 
breast cancer are higher among women who depend exclusively on SUS. 
DESCRIPTORS: Breast Neoplasms, diagnosis. Mammography, utilization. Early Detection 
of Cancer. Mass Screening. Health Surveys. 
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INTRODUCTION
In Brazil, as in many other countries, breast cancer is the most common type of cancer among 
women. Mortality rates by the disease, estimated since 1980, show an increase in the five 
regions of the Country1. This increase can be explained, in part, by the increased incidence 
of the disease due to greater exposure of women to risk factors related to the urban lifestyle, 
which interferes directly in the gradient of exposure to reproductive factors. However, since 
the end of 1990, a decrease in mortality in the capitals of the South and Southeast regions 
can be observed. At the same time, a large annual increase in the rates of deaths among 
women from interior cities is perceived, mainly in the North and Northeast regions, which 
suggests that the reproductive and sexual changes, initiated in major urban centers, were 
quickly adopted by women of other cities, even in low-income areas. On the other hand, the 
reversal in mortality, which began in the capitals, became possible by the access to diagnostic 
and therapeutic means of women in the early stages of the disease2.
The results of large randomized clinical trials published in the 1970s and 1980s3,4 showed 
that mammographic screening would be able to reduce by 20%–30% the mortality by this 
malignant neoplasia. In fact, the introduction of population mammographic screening has 
contributed to decrease mortality in several developed countries, since the examination 
allows detection of tumors still in early stages of the disease, enabling the patients to have 
good response to the therapies available today5,6.
In 2004, the Brazilian Ministry of Health released the document of Consensus for Control of 
Breast Cancer, recommending the annual clinical breast examination as important action 
for detecting the disease to women from the age of 40 and the mammographic screening 
every two years to women between the ages of 50 and 697.
Some surveys conducted in the Country since the 2000s estimated the coverage of 
mammography within the recommended age range from 50 to 69 years. The Household Survey 
on Risk Behavior and Reported Morbidity of Non-Communicable Diseases and Injuries, held in 
2003 in 15 capitals, estimated that the mammography coverage in the two years preceding the 
survey varied between the surveyed cities – from 37% in Belém (PA) to 77% in Vitória (ES)8. In 
2008, the National Household Sampling Survey (PNAD – Pesquisa Nacional por Amostragem de 
Domicílio) estimated a mammography coverage of 54.2% (95%CI 53.5–55.0) among women from 
50 to 69 years in the two years preceding the interview, with a great difference between the North 
(35.3%) and Southeast (63.8%) regions9. In 2013, the National Health Survey (PNS - Pesquisa 
Nacional de Saúde) estimated, for this same age group, a 60.0% coverage (95%CI 58.8–61.3) 
for all Brazil, and a great variation amplitude between regionsa.
Based on population surveys, one can verify that the coverage self-reported by women of the capitals 
of the Country, when compared to that of women living in other cities, was already greater since 
2003. From PNAD 2003 and VIGITEL 2007 data, authors estimated that the coverage of the exam in 
Brazilian capitals was 70%, ranging from 41.2% in Porto Velho (RO) to 82.2% in Florianópolis (SC)10.
This scenario reinforces the hypothesis that the expansion of access to mammographic 
screening depends not only on the supply and quality of the exams, but also on the 
organization of the health-care network and accession of professionals to the existing 
guidelines. Thus, this study aimed to analyze whether the actions of early detection for 
breast cancer, initiated with the medical request for mammography, differ between users 
of the Brazilian Unified Health System (SUS) and those who have private health insurance.
METHODS
For this study, we used data collected in the PNS carried out by the Brazilian Ministry of 
Health in partnership with IBGE, which aimed to assess the health, lifestyle, and health-care 
of the adult population in Brazil11.
a Ministério da Saúde (BR), 
DATASUS. Informações de 
Saúde. PNS – Pesquisa Nacional 
de Saúde – 2013: módulo de 
cobertura de mamografia entre 
mulheres de 50 anos ou mais. 
Brasília (DF); s.d. [cited 2017 Jan 
20]. Available from: http://tabnet.
datasus.gov.br/cgi/deftohtm.
exe?pns/pnskb.def
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PNS is a household survey that belongs to the Integrated System of Household Surveys (SIPD) 
of IBGE. It has a stratified and conglomerate sampling with three stages of selection. The 
census tracts formed the primary sampling units and, as part of SIPD, the selection of these 
units was obtained by simple random sampling, from the Master Sample. The stratification 
of the primary sampling units in PNS was the same used in the Master Sample12.
In the second stage, a fixed number of households was selected in each primary sampling 
unit, from the National File of Addresses for Statistical Purposes. In the third stage, within 
each household sampled, a resident with 18 years or older was selected at random from a 
list of eligible residents built at the time of the interview.
Of the 69,954 selected and occupied households in which residents were selected for 
interview, 60,202 individuals agreed to participate, which led to a response rate of 86%11,13.
PNS data were collected by trained interviewers using handheld computers (personal 
digital assistant). The selected adults responded to the questionnaire on sociodemographic 
characteristics, health self-assessment, lifestyle, morbidity, accidents and violence, women’s 
health, children’s (under two years) health, oral health, elderly health, and health system 
performance. In addition, anthropometric data blood pressure were measured and biological 
material was collected. More details on the sampling process and data collection of PNS 
were described by Souza-Junior et al.13.
The data of mammography for the population of women between 50 and 69 years were 
accessed in the module K of PNS “Health of individuals of 60 years or older and coverage of 
mammography among women of 50 years or older.”
The module R of PNS, regarding women’s health, contained questions on the following 
variables: “Having medical request for mammography” and “Having performed the 
examination after the request and receiving the result,” as well as the respective time between 
each situation and reasons for not having done the exam after medical request and the time 
between performing the exam and receiving the result.
Initially, we estimated the coverage of mammography among the target population of 
the screening (women between 50 and 69 years) from the proportion and respective 95% 
confidence intervals (95%CI) of women who reported having done the examination in 
the past two years, according to presence or absence of health insurance by regions of the 
Country. Then, we estimated the proportions and respective 95%CI of having medical request 
to perform mammography according to age group, with stratification between women using 
SUS and those with health insurance.
For assessing the factors related to having mammography medical request, we estimated 
crude and adjusted odds ratios (OR) and respective 95%CI by logistic regression. For this 
analysis, we selected the following factors: age group (40–49; 50–59; 60–69; 70 or older); 
education level (without education or some elementary school; elementary or middle school 
or some high school; high school or some higher education; higher education degree); region 
of the Country; race/skin color (white; nonwhite); and having private health insurance. 
Among the women who could not perform mammography after having medical request, 
we estimated the frequencies and 95%CI of the most frequent reasons informed, according 
to presence or absence of health insurance.
Additionally, we estimated the distribution of women according to the difference in time 
between examination and result, separating SUS users and those with health insurance into 
the following categories: less than 1 month; 1├ 3 months; 3├ 6 months; 6 months or more; 
has not yet received; never received.
The analyses were carried out using the SPSS statistical program version 21.014. For being a 
survey with stratification of the primary sampling units and selection by conglomerates in three 
stages, we considered the complex sampling design throughout the statistical analysis of data.
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PNS was approved by the Human Subject Research Ethics Committee of the Brazilian Ministry 
of Health (Opinion 328,159, June 26, 2013). All participants signed the informed consent form.
RESULTS
From the information reported in module K, among women from the target age group for 
screening breast cancer in Brazil (50 to 69 years), 60.0% (95%CI 58.8–61.3) performed a 
mammography in the past two years. This proportion ranged from 38.7% in the North region 
to 67.9% in the Southeast region. The proportion of women who performed the examination 
was much higher among those with health insurance (79.5%) when compared to SUS users 
(51.0%), condition that was repeated in all regions of the Country (Table 1). 
Regarding the information on having medical request and referrals, contained in the module 
R, 66.7% of women have had a mammography request made by a doctor, and this proportion 
was higher (72.7%) for women aged between 50 and 59 years (Table 2). However, the 
percentage of women who reported having had medical request for mammography presented 
great difference according to presence or absence of health insurance (83.9% and 59.3%, 
respectively). In addition, a higher number of women among those with health insurance was 
performing mammography outside the age range indicated for the population screening. For 
women from 40 to 49 years, 84.5% with health insurance reported having received medical 
request, a significantly higher ratio than that reported for SUS users (58.1%). Similarly, for 
women with 70 years or older, 83.9% with health insurance had the medical request, while 
only 59.4% of SUS users had it. Among those with health insurance, we draw attention to 
the similar proportions of women between 40 and 49 years and 60 and 69 years (84.5% and 
83.5%, respectively) with mammography medical request (Table 2). 
The reasons that were most positively associated with having had a mammography medical 
request were: having health insurance (OR = 2.60, 95%CI 2.20–3.07), being within the target 
age groups of the screening (OR 50–59 years = 1.47, 95%CI 1.27–1.71; OR 60–69 years = 1.20, 
95%CI 1.03–1.41), and being white (OR = 1.23, 95%CI 1.08–1.40). Education level was also 
positively associated: the higher the education level, the greater the chance of having a 
mammography request. On the other hand, living in different regions than the Southeast 
presented lower chance of having mammography medical request (Table 3). 
Table 1. Coverage of mammography among women from 50 to 69 years with and without private health 
insurance, according to regions of Brazil. Brazil, 2013.
Region
All Without health insurance With health insurance
% 95%CI % 95%CI % 95%CI
North 38.7 36.0–41.5 31.9 29.1–34.8 69.5 63.5–74.9
Northeast 47.9 45.7–50.1 41.0 38.6–43.4 77.4 73.2–81.0
Southeast 67.9 65.9–69.8 59.3 56.8–61.8 81.4 78.8–83.7
South 64.5 61.4–67.5 56.6 53.1–60.1 80.0 74.4–84.7
Midwest 55.6 52.8–58.3 46.0 42.7–49.3 72.3 68.4–75.9
Brazil 60.0 58.8–61.3 51.0 49.5–52.4 79.5 77.6–81.2
Table 2. Proportion of women who reported having had medical request for mammography by age 
group, according to presence or absence of private health insurance. Brazil, 2013.
Age group (years)
All Without health insurance With health insurance
% 95%CI % 95%CI % 95%CI
40–49 65.9 63.9–67.7 58.1 55.8–60.3 84.5 81.4–87.0
50–59 72.7 70.3–74.9 66.2 63.3–68.9 89.5 86.2–92.1
60–69 68.2 65.5–70.8 61.3 58.1–64.3 83.5 78.6–87.4
≥ 70 54.9 51.6–58.1 45.7 41.7–49.6 74.1 68.8–78.6
Total 66.7 65.3–67.9 59.4 57.8–60.8 83.9 81.8–85.7
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Of the women who received medical request for mammography, 5.4% (95%CI 4.8–6.0) were 
unable to perform the examination. This percentage was more than four times higher 
among those who had no private health insurance when compared to those who had 
(7.6%, 95%CI 6.7–8.6 versus 1.7%, 95%CI 1.2–2.3, respectively).
The most reported reasons for not being able to perform the exam after medical request were: 
not thinking it was necessary; having the test scheduled, but not yet performed; and not being 
able to schedule it (Table 4). The difference between those with private health insurance and 
SUS users who failed to schedule the mammography was great (3.7% and 20.0%, respectively). 
However, this observation should be viewed with caution because of the small number of 
women interviewed who composed some of the response categories for that question.
Among the interviewees, 74.8% reported receiving the test results less than a month after it was 
performed. This percentage was higher for those who have health insurance (86.6%). Although 
only 0.3% of the interviewees had not received the test results, this percentage decreases 
from 0.47% among SUS users to 0.05% among those with private health insurance (Table 5).
Table 3. Factors associated with having had mammography medical request. Brazil, 2013.
Factor crudeOR 95%CI OR* 95%CI
Age group (years)
40–49 1.00 - 1.00 -
50–59 1.38 1.20–1.59 1.47 1.27–1.71
60–69 1.11 0.96–1.29 1.20 1.03–1.41
≥ 70 0.63 0.54–0.74 0.66 0.56–0.79
Education level
Illiterate/some elementary or middle school 1.00 - 1.00 -
Elementary or middle school/some high school 1.56 1.32–1.84 1.27 1.06–1.52
High school/some higher education 2.31 2.00–2.65 1.66 1.42–1.94
Higher education degree 3.66 2.91–4.59 2.03 1.59–2.60
Color/race
Nonwhite 1.00 - 1.00 -
White 1.78 1.59–1.99 1.23 1.08–1.40
Region
Southeast 1.00 - 1.00 -
North 0.29 0.24–0.34 0.35 0.29–0.42
Northeast 0.41 0.35–0.48 0.53 0.45–0.62
South 0.77 0.65–0.92 0.78 0.65–0.94
Midwest 0.60 0.51–0.70 0.62 0.53–0.73
Having health insurance
No 1.00 - 1.00 -
Yes 3.57 3.07–4.16 2.60 2.20–3.07
* Adjusted for all variables in the table.
Table 4. Main reasons for not performing mammography after receiving medical request. Brazil, 2013.
Reasons
All Without health insurance With health insurance
n % 95%CI n % 95%CI n % 95%CI
Scheduled examination 141 23.0 18.3–28.4 115 21.2 16.3–27.1 26 36.3 23.9–50.8
Did not think it was necessary 167 27.2 22.1–33.0 147 27.1 21.6–33.4 20 28.0 16.5–43.3
Failed to schedule 111 18.1 13.5–23.9 108 20.0 14.8–26.5 3 3.7 1.5–8.7
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DISCUSSION
The coverage self-reported by women from 50 to 69 years about the performance of 
mammography in the past two years in Brazil, from PNS 2013 data, was 60.0%. This proportion 
is higher than that verified by PNAD 2008 (54.2%)9, but still shows great variation between 
regions. Additionally, the coverage of mammography among women in the recommended 
age group (50–69 years) varies greatly between those who depend exclusively on SUS (51.0%) 
and those with private health insurance (79.5%).
In 2004, the Brazilian Ministry of Health released the first document of Consensus for Control 
of Breast Cancer, which established the age group of 50–69 years as target of the screening. 
This age group was confirmed as target, in 2015, in the Clinical Guidelines for Control of Breast 
Cancer, also approved by the Brazilian Ministry of Health, after extensive literature review 
and public consultation15. Although there is much discussion around this prioritization of 
age, current scientific evidence confirms that women in this age group are those that most 
benefit from the mammographic screening5,16.
This study allows evaluating, for the first time with national representation, fundamental 
steps and access barriers to ensure the effectiveness of a screening program, such as having 
the request made by a doctor and the reasons affecting this condition. Our results showed 
that 66.7% of the women interviewed had a medical request for mammography, but, again, 
we observed great variation between SUS users (59.4%) and those with private health 
insurance (83.9%). We draw attention, however, to the fact that the higher proportions of 
women with medical requests among those met by SUS belong to the age group of 50–59 and 
60–69 years, suggesting that SUS services have a tendency to follow the recommendations 
of the Ministry of Health. Among women with private health insurance, the percentage of 
mammography request in the age group of 40–49 years (84.5%) is similar to that found among 
women of 60–69 years (83.5%), which are part of the target population of the screening.
The scientific evidence is clear in showing that the balance between the benefits and risks of 
mammographic screening is favorable for women between 50 and 69 years. Younger women 
tend to present a higher amount of false positive results, which may bring damages due to 
overdiagnosis and overtreatment17. The cumulative risk among women from 40 to 49 years, 
annually subjected to a mammography, of having a false positive result in 10 years is about 60%18.
The factors that were most positively associated with having a mammography medical request 
are: having private health insurance, high education level, and being white. Live in the North 
and Northeast regions reduced the chances of having a mammography medical request. Other 
studies conducted in the Country have already indicated the difficulty of access among women 
from the economically poorest regions of Brazil19,20. However, it is possible to observe that, once 
having the medical application, almost all women can perform the mammography. Only 5.4% 
of women who had medical request for mammography had not yet carried out the examination 
at the time of the interview. However, this percentage was more than four times higher among 
those who had no private health insurance when compared to those who had (7.6% versus 1.7%, 
respectively). Although this datum should be viewed with caution due to the small number of 
Table 5. Time interval between performing and receiving the result of mammography. Brazil, 2013.
Time interval
All Without health insurance With health insurance
% 95%CI % 95%CI % 95%CI
< 1 month 74.8 73.2–76.4 67.3 65.2–69.4 86.6 84.5–88.5
1├ 3 months 19.0 17.6–20.5 25.1 23.3–27.1 9.4 7.8–11.3
3├ 6 months 1.7 1.4–2.1 2.3 1.8–2.8 0.8 0.5–1.4
≥ 6 months 1.4 1.0–1.9 1.5 1.0–2.1 1.3 0.8–2.2
Not yet received 2.3 1.9–3.0 2.9 2.2–3.7 1.5 0.9–2.5
Never received 0.3 0.2–0.5 0.5 0.3–0.8 0.0 0.0–0.1
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observations, the great difference found between SUS users and those with health insurance 
that failed to schedule the examination called our attention (20% and 3.7%, respectively).
Based on data recorded in the SUS information systems, it is possible to note the existence 
of major inequalities between the regions of the Country not only for mammography 
examination, but also for the essential steps to ensure the success of a screening program: 
access to diagnosis and treatment for women with suspicious screening tests19. As identified 
by the coverage self-reported in PNS, the data of the SUS health information systems confirm 
the North region, followed by the Northeast, as the regions that stand out by presenting 
lower possibility of early detection and access to surgery. 
Although lower mammography coverage has been identified among women who depend 
on SUS, an expansion in the supply of mammography has been observed in the Country. 
Data from PNAD 2003 and 2008 had already shown an increase of 42% among women 
without health insurance, greater than that verified between those with health insurance20.
The data presented here strengthen what was already observed in other studies, which show that 
the access barriers for screening breast cancer are higher among the population living outside 
major urban centers and depending exclusively on services provided by SUS. Our results indicate 
that, perhaps, the first important access barrier to early detection of breast cancer is getting a 
medical request for performing mammography. Almost 70% of the interviewed 40-year-old or 
older women had a medical request for mammography, and this percentage was higher among 
those who had private health insurance. However, we observed that, once having the medical 
request, only 5% of women were unable to perform the examination; but, again, we noted 
inequality of access when the data were stratified by having private health insurance or not. 
Less than 2% of women covered by private health insurance failed to perform the examination 
after medical request. 
It is important to note that the gains in relation to population mammographic screening 
should be considered and evaluated constantly in the light of scientific knowledge21,22, within 
what is proposed as organized strategy. Surely, there are plenty of existing inequalities in 
the access to health-care, and the screening depends on a number of conditions that begin 
with women’s awareness and professional compliance with the clinical guidelines currently 
in force. Therefore, the implementation of the organized screening for breast cancer can set 
the capacity for early detection of cases and thus direct efforts to the appropriate treatment 
for effectively decreasing mortality by breast cancer. 
Efforts should be made to expand the actions of early detection of breast cancer, reducing 
the inequalities of access in all stages of this process and ensuring that all women can benefit 
from the appropriate treatment. Warning strategies to the problem and investment in the 
training of professionals in the health-care network, with rationalization of the provision 
of services, should be prioritized within the national cancer control policy and in the 
comprehensive care to women.
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